Michikado Iwata

Suggest Changes
Learn More
OBJECTIVES We tested the hypothesis that angiotensin II type 1 receptor blocker (ARB) may improve beta-adrenergic receptor (AR) coupling in heart failure (HF) after myocardial infarction (MI). (More)